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Individual antigenic determinants on antibodies were originally described by 
Kunkel  et  al.  (1).  Subsequently,  the  determinants,  termed  "idiotypes"  by 
Oudin  (2), have been described in  antibody populations made in  response to 
bacterial antigens (3) and to haptens (4). The antiidiotypic antisera are usually 
made in homologous or even heterologous species. Absorption of the antiidio- 
typic  antisera  with  preinoculation  serum  or  IgG from  the  individual  whose 
idiotype  is  being  studied  might  not  remove  antibodies  specific  for  constant 
areas of variable (V)  1 regions of a  particular V-region subclass represented in 
the antibody (idiotype) population. Certainly, allotype matching of donor and 
recipient  restricts  one  to  matching  for  only  the  presently  known  allotypes. 
Idiotypic probes of V-region genetics might be more useful if a technique could 
be used that would elicit only antibodies in the antiidiotypic antiserum specific 
for hypervariable regions in the idiotypic population. 
Evidence is presented here that determinants characteristic of idiotypes can 
induce synthesis of "autoantiidiotypic antibodies" within the same individual. 
This system might serve as a  tool for studying hypervariable-region genetics 
and provide a different approach to questions of autoimmune processes. 
Materials and Methods 
Animals.--Outbred  New Zealand White rabbits were used. 
Haptens.--The  hapten  p-aminophenyl-N-trimethylammonium chloride (R4N) was  ob- 
tained from Dr. V. Peter Kreiter, Glenwood, N.Y. Further purification was done by recrys- 
tallizing  R4N  from methanol. N,N-dimethyl-p-phenylenediamine  dihydrochloride (R3N) 
was obtained from the Eastman  Kodak Co., Rochester, N.Y. and was purified further  by 
recrystallization from ethanol, p-nitrobenzoic acid (PNBA) was obtained  from Matheson 
Coleman and Bell, East Rutherford, N.J. and was recrystallized from ethanol. 
Antigen.--The hapten R4N was coupled to keyhole limpet hemocyanin (KLH) by diazoti- 
zation at pH 9-9.5 using a weight ratio of 40 mg/g KLH. The KLH-R4N conjugate was 
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t Abbrcdatio~  used in this paper: BSA, bovine serum albumin; CFA, complete Freund's 
adjuvant;  IFA, incomplete Freund's adjuvant;  KLH, keyhole limpet hemocyanin; PNBA, 
p-nitrobenzoic acid; R3N, N,N-dimethyl-p-phenylediamine  dihydrochloride; R4N, p-amino- 
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dialyzed exhaustively against cold neutral buffer. The KLH-R4N  (4-8 rag) was emulsified in 
either complete (CFA) or incomplete (IFA) Freund's adjuvant (Difco Laboratories, Detroit, 
Mich.) and injected in 4-6 sites subcutaneously over the dorsum. 
Anti-R4N Purif~ation.--Blood  was collected from the marginal ear vein and allowed to 
clot,  then the serum was  separated  by centrifugation and stored without preservative at 
--20°C. Before purification all sera were clarified by centrifugation to remove lipid and red 
cell debris. R4N was diazotized tobovine serum albumin (BSA) as described for KLH. Sepha- 
rose 4_B (Pharmacia Fine Chemicals, Inc., Piscataway N. J.) was suspended in an equal volume 
of 0.1 M bicarbonate buffer, pH 9.0. Sepharose was activated by adding cyanogen bromide to a 
final concentration of 0.42 M for a total time of 9 rain. The cyanogen bromide was removed by 
filtration, then BSA-R4N was added  (2 mg/ml Sepharose) and allowed to react for 24 h  at 
4°C.  Mter incubation the Sepharose BSA-R4N was packed in a  column and washed with 
0.01 M  NH40H  (pH 9.0) and then washed again with neutral buffer until the optical density 
of  the effluent dropped  below 0.010  measured at  280  nM.  Antiserum was  applied  to  the 
Sepharose BSA-R4N column at a ratio of 2 ml/ml bed volume. The serum was washed through 
the column with neutral buffer until the OD at 280 nM dropped below 0.010.  1 vol of physio- 
logical saline was washed through the column to minimize buffering capacity. This step was 
followed by adding 1 M propionic acid to the column to elute antibody. The eluted protein was 
dialyzed against distilled water to remove propionic acid before exhaustive dialysis against 
neutral buffer. The eluted protein was concentrated by pervaporation. 
F(ab')2  Preparation.--F(ab')2  fragments  of  purified  anti-R4N  antibodies  were  made 
using pepsin digestion at pH 4.3 followed by chromatography on Sephadex G-150 (Pharmacia 
Fine Chemicals, Inc.) (5). 
F(ab') 2 Polymerization.--Samples  of F (ab')2 fragments (2 mg/ml in 0.1 M phosphate buffer, 
pH 7.0) were treated with a 250-fold M  excess of glutaraldehyde (Fisher Scientific Company, 
St. Louis, Mo.) and the reaction was stopped by adding lysine to a final 0.1 M concentration. 
F(ab')2 Iodination.--F(ab')2  was iodinated using carrier IC1  (redistilled) and  125I (New 
England Nuclear,  Boston, Mass.)  according to  McFarlane  (6).  Incorporation of  125I was 
1.2-1.6 atoms I/molecule F(ab')2. Mter dialysis, the samples were assayed for TCA-precipit- 
able radioactivity. All samples showed precipitable activity exceeding 98%. 
Indirect Radioimmunoassay.--The  technique is essentially as detailed previously (7). Briefly, 
0.25-/zg  aiiquots of  1~5I F(ab')2 were mixed and incubated with 10-20/zl aliquots of anti- 
idiotypic antiserum and then 0.3-0.6 ml monospecific goat antirabbit Fc antiserum was added. 
Superuate and precipitates were assayed for radioactivity in a  Nuclear-Chicago automatic 
gamma-well scintillation counter (Nuclear-Chicago Corp., Des Plaines, Ill.) equipped with a 
3-inch NaI(Th) crystal. 
Compaitive  Inhibition  Reaaions.--Aliquots  of  BSA-R4N  were  added  to  the  autoanti- 
idiotypic antiserum before the addition of  [l~SI]F(ab')2. In the studies with free hapten, 
hapten was dissolved in neutral buffer and the pH was adjusted to 8.0.  Hapten was added to 
[l~SI]F(ab')2 anti-R4N antibodies and incubated overnight in the cold. The following day, 
autoantiidiotypic antiserum was added and the tubes were incubated at 37°C for 4 h. Goat 
anti-Fc was added and the tubes were incubated at 37°C for 2 h  and overnight in the cold 
room.  In experiments using whole serum for inhibition, [l~SI]F(ab% anti-R4N  and  whole 
serum inhibitors were mixed before adding the autoantiidiotypic antiserum. The quantities of 
goat anti-Fc added to the tubes were adjusted to accommodate the increase in Fc present in 
the reactions. 
Injection Schedule.--The  overall bleeding and injection schedule is shown in Table I. The 
rabbits were immunized and serum was collected over a  period of  189 days.  Following this 
schedule,  a  432-day  rest period was  allowed.  During this time,  anti-R4N  antibodies from 
individual rabbits were purified from a pool of serum collected during the first 189-day period. 
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30 mg/ml using a broad-spectrum goat antiserum. Only the IgG2 line was developed. Neither 
IgG1  (8)  nor  IgM protein  was detected.  These  antibody  preparations  were digested with 
pepsin  to prepare  F(ab')2 fragments.  F(ab')2 fragments were tested  for the absence of Fc 
determinants  by immunodiffusion and immunodiffusion inhibition using a monospecific goat 
anti-Fc antiserum.  Part of the F(ab')2 preparation  was polymerized with glutaraldehyde for 
reinjection. 
Polymerized F(ab')2 in CFA was injected back into the rabbit that produced the F (ab  r) 2 
on day 621. The schedule in Table I was followed through day 660. 
RESULTS 
Sera collected between days 641  and 660 were tested by radioimmunoassay 
against [mI]F(ab')2 fragments of anti-R4N antibodies produced earlier.  Table 
II shows the results  of homologous and heterologous assays.  Each rabbit  re- 
sponded well against  anti-R4N antibodies produced in itself and its antibody 
was specific only for its own anti-R4N antibodies, not the anti-R4N antibodies 
made  in  other  individuals.  Pooled  normal  rabbit  serum  and  preinoculation 
serum  from  the  five  test  animals  showed no reaction  with  the  labeled  anti- 
R4N  F(ab~)~  fragments.  In  addition,  direct  immunodiffusion  assays  using 
either  pooled anti-R4N  antiserum  or  the purified  F(ab~)2  fragments  and  the 
660-day autoantiidiotypic antiserum were negative for all individuals. 
Control experiments  were performed  to confirm both  the  absence of small 
bits  of  immunizing  antigen  from  the  anti-R4N  F(abP)2  fragments  and  the 
absence of BSA-R4N that might have coeluted from the  affinity chromatog- 
raphy  columns.  Assays also  were performed  to  further  substantiate  the  im- 
TABLE I 
Bleeding and Injection Schedule for Autoantiidiotypic Antibody Production 
Day  Treatment 
0  Bleed, inject KLH-R4N (CFA) 
21  Bleed 
44  Bleed, inject KLH-R4N (CFA) 
63  Bleed 
84  Bleed 
150  Bleed, inject KLH-R4N (IFA) 
170  Bleed 
189  Bleed 
Pool  antisera,  specific purification  of anti-R4N,  pepsin  digestion, 
glutaraldehyde  polymerization 
621  Inject Glu-F(ab')2 (anti-R4N) 
634  Inject Glu-F (ab') 2  (anti-R4N) 
641  Bleed, inject  Glu-F(ab')2  (anti-R4N) 
647  Bleed 
653  Bleed 
660  Bleed L. SCOTT RODKEY  715 
munoglobulin  nature of the iodinated proteins. Table III shows the results of 
these assays. 
Indirect  assays  suggested  that  BSA-R4N  was  not  bound  to  the  labeled 
F(ab')2 fragments because fragments from all individuals showed no reaction 
with a high-fiter anti-BSA antiserum. The possibility that fragments of KLH 
or  KLH-R4N  complexes  were  carried  through  the  purification process  and 
residual anti-KLH-R4N antibodies in the 641-660-day sera might be reacting 
with this complex bound to [1251]F(ab')2 anti-R4N was tested using a heterolo- 
gous high-titer anti-KLH-R4N antiserum. The lack of such reaction suggested 
that  that  possibility had  not  occurred.  The  immunoglobulin nature  of  the 
F(ab')2 preparations was substantiated by reaction with antiallotype antisera 
(Table lII). The allotype distribution  of the whole serum as tested by standard 
immunodiffusion assays is given in Table 111. 
TABLE II 
Reactions  of  Autoantiidiotypic  Antisera  with  [1251]F(ab')2 fragments  of 
A nti-R4N A ntlbodies 
Antiserum 
[mI]F(ab'), 
B-18  B-19  B-21  B-22  B-26 
Preinoc*  0.8  1.3  1.5  2.3  2.3 
PNRS:~  1.1  1.5  2.0  2.3  1.2 
B-18 anti-B-18  17.0  2.3  0.6  2.3  2.7 
B-19 anti-B-19  0.9  39.3  1.6  2.0  2.4 
B-21 anti-B-21  0.6  3.4  40.7  1.3  2.3 
B-22 anti-B-22  0.1  0.7  0.3  23.3  0.7 
B-26 anti-B-26  0.2  1.6  0.1  0.3  23.3 
* Preinoculation (day 0) serum from each individual. 
Pooled normal rabbit serum. 
TABLE III 
Assays  of Antigenic Nature of 12~I-Labded Proteins 
Antiserum 
[I~I]F  (ab')~ 
B-18  B-19  B-21  B-22  B-26 
Anti-BSA  1.0  1.0  1. I  0.8  1.3 
Anti-KLH-R4N  0. I  0.1  0.1  0.8  I. 2 
Anti-Aal  91.3  91.5  86.4  77.5  91.9 
Anti-Aa2  0.7  0.7  0.9  2.6  0.4 
Anti-Aa3  1.8  2.6  2.8  37.1  1.3 
Anti-Ab4  93.9  95.5  90.9  93.5  94.0 
Anti-Ab5  0.8  1.3  4.5  1.1  0.5 
ID allotype*  alb4  alb4  alb4  ala3b4  alb4 
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The close association of the idiotypic determinant on the F(ab')2 fragments 
with  the  antigen-binding  site was  examined. A  standard reaction of labeled 
anti-R4N F(ab02 fragments with corresponding antiserum was inhibited with 
various amounts of BSA-R4N for the two individuals (B-19, B-21) with highest 
percentage homologous reactions. These results (Fig. 1) show that the reaction 
was inhibitable by BSA-R4N. BSA alone did not inhibit the reaction. 
Free hapten inhibition studies were done to verify and extend the results 
obtained with BSA-R4N inhibition.  [l~6I]F(ab')2 fragments of anti-R4N  anti- 
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FIO. 1. Inhibition of homologous reactions of B-19 and B-21  [125I]F(ab')2 anti-R4N frag- 
ments with B-19 and B-21 autoantiidiotypic antisera with unlabeled BSA-R4N. 
body from rabbits B-19 and B-21 were incubated with various concentrations 
of free haptens and the reactions obtained were calculated as percentage of 
uninhibited controls. These experiments are summarized in Table IV. Homolo- 
gous free hapten (R4N) inhibited the reaction in each case to a much greater 
degree than  did  either a  structurally similar hapten  (R3N)  or an unrelated 
hapten  (PNBA).  These  results  confirm  the  earlier  results  using  BSA-R4N 
and show the specificity of the reaction for the R4N hapten. 
Additional inhibition studies were done to determine whether or not the pep- 
sin  treatment had  altered the  native  anti-R4N  antibodies  and perhaps had 
made a "buried" idiotypically specific determinant available for reaction. The 
[12SI]F(ab')~ anti-R4N fragments were mixed with aliquots of untreated whole L.  SCOTT RODKEY  717 
serum followed by addition of the  autoantiidiotypic  antisermn. The results  of 
these experiments  are shown in Table V. Aliquots of the whole serum  used to 
isolate the anti-R4N antibodies inhibited the reaction markedly,  while the same 
serum  showed no inhibition  after passing it through  the Sepharose  BSA-R4N 
column.  Normal rabbit serum showed no inhibitory capacity. 
DISCUSSION 
Idiotypes  or  "individual  antigenic  specificities"  have  served  as  immuno- 
chemical  markers  for  studying  antibody  V  regions  in  various  systems  since 
TABLE IV 
Effect of Free Haptens for Inhibition of the Reaction of [1251]F(ab')2 Anti-R4N Antibodies from 
Rabbits B-19 or B-21 and  Homologous Autoantiidiotypiv  Antisera 
Final molar concentration  of free hapten* 
2.5  X  10  ~  2.5 X  IDa  7.7  X  10-*  2.5  X  10-*  7.7  X  10  -6 
Free R4N 
B-19 system* 
B-21 system* 
Free R3N 
B-19 system:l: 
B-21 system:~ 
Free PNBA 
B-19 system]~ 
B-21 system* 
36.1  40.7  47.0  57.2 
40.3  41.7  --  57.7 
53.9§  66.7  --  77.6 
53.5  68.7  --  85.1 
96.7  102.4  --  102.9 
93.4  96.6  --  98.8 
* Concentration of free hapten before adding goat anti-Fc. 
* Refers  to  [125I]F(ab')2  reaction  with  homologous autoantiidiotypic  antisera. 
§ Percentage of the reaction obtained in the absence of inhibitor. 
TABLE V 
Effect  of  Undigested  Whole  Antibody  on  the  Idiotype-Autoantiidiotype  Reaction  of  Rabbits 
B-19 and B-21 
Inhibitors 
10 vl untreated  20 td untreated  20.1 absorbed  20 gl NRS§ 
whole serum*  whole serum*  whole serum~ 
B-19 system¶  19.411  10.0  100.0  99.3 
B-21 system¶  17.1  14.7  97.1  100.0 
* Whole serum from pool of 21-189 day antisera. 
J/Whole serum from pool of 21-189  day antisera after passage through  Sepharose-BSA- 
R4N immunoadsorbent column. 
§ Pooled normal rabbit serum. 
¶ Refers to [12~I]F(ab')2 reaction with homologous autoantiidiotypic antiserum. 
I[ Percentage of the reaction obtained in the absence of inhibitor. 718  S'£UDIES  OF  AUTOANTIIDIOTYPIC  ANTISERUM 
their original description (1). Idiotypic antibodies found in artificially acquired 
active immune states in outbred animals usually are only a  subpopulation of 
the  total  antibody with  that  particular  specificity (9)  and  are unique  to  a 
single individual.  Cross  reactions have been noted among strains  of inbred 
mice  (10).  The data in Table II suggest that the autoantiidiotype reactions 
studied  here  are  specific  for  individuals,  and  the  percentage  of  anti-R4N 
F(ab')2 fragments involved in the reactions suggest that the reactions involve 
only part of the total population of anti-R4N antibodies studied. 
The immunoglobulin nature of the labeled radioimmunoassay test antigen 
was verified by analysis for allotypic determinants coded by the a and b locus. 
The results of the quantitative allotype assay of the labeled F(ab')2 fragments 
paralleled  the  results  of  the  standard  immunodiffusion allotype  assay  per- 
formed on preinoculation serum. 
The intimate involvement of V-region structures in determining idiotypic 
specificity was shown in hapten inhibition studies of idiotypes done by Brient 
and Nisonoff (11). Whether the inhibition was due to direct "masking" of the 
binding site (idiotypic site) or to perterbation of an area adjacent to the binding 
site is still controversial. Inhibition data do, however, support the contention 
that the idiotypic site (or sites) are contained within the V domain. The reac- 
tion reported here was specifically inhibitable with hapten coupled to BSA and 
with free hapten. It parallels other idiotypic systems in that respect. In addi- 
tion, the reaction appeared to be mediated by structures present on the surface 
of native untreated anti-R4N antibodies since whole untreated serum from the 
pool used to make [12~I]F(ab')2 fragments inhibited the reaction of the labeled 
fragment with  the  autoantiidiotypic antiserum.  Whether  some  degradation 
might have occurred in vivo subsequent to secretion of the antibody from the 
plasma cell would be a possibility for all idiotypic systems. 
Synthesis of antiidiotypic antibody by the same animal that produced the 
idiotypic antibody originally appears to pose a problem relating to the axiom of 
nonresponsiveness to "self"-antigens  after immunological maturation. Auto- 
responsiveness  to  thyroglobulin  (12)  and  components  of  the  eye  lens  and 
spermatozoa is well recognized. This usually is  explained  (13)  by  assuming 
that  (a)  the components in question are normally inaccessible to blood and 
lymph and/or (b) they were not present as such in the body when tolerance to 
self-components was establsished during embryonic life.  Clearly, explanation 
(a)  does not fit the present  circumstance because  the  antigen  (idiotype)  in 
question presumably was a B-cell receptor site and was part of the lymphatic 
system. The possibility that the determinant was not present during the "self- 
recognizing" period of development suggests that the B  cells responsible for 
synthesizing these antibodies matured subsequent to immunological matura- 
tion. 
Further studies using autoantiidiotypic antibodies are being directed toward 
genetic analysis of V regions. The  ability of an individual to synthesize anti- L.  SCOTT RODKEY  719 
bodies specific for its own antibody V-region structures immediately increases 
theoretically the amount of genetic material needed for germ-line theories of 
antibody  diversity  (14).  Other  studies  could  be  directed  to  determining 
whether autoantiidiotype antibodies are elicited by an immune response with- 
out  artificially reintroducing  the  antibodies.  Such  a  study might  suggest  a 
mechanism for switching off synthesis of antibody by one clone of cells and 
establishing new clones. 
SUMMARY 
Rabbits  were  immunized with  a  hapten-protein  conjugate  and  sera  were 
collected for  189  days.  The  antihapten  antibodies were  purified  by affinity 
chromatography,  then  the  same  animal  that  synthesized  the  antibody was 
reinjected with polymerized F(ab')~ fragments of antihapten antibodies. Sera 
were collected after autoimmunization and tested by an indirect radioimmuno- 
assay technique for reaction with [l~SI]F(ab')~ fragments of the  original anti- 
hapten antibody. Results showed that  each individual responded to its own 
F(ab')2 and the antisera were specific for antihapten antibodies of that indi- 
vidual. Quantitative allotype assays established the immunoglobulin nature of 
the labeled test antigen. Inhibition assays showed that the reaction was spe- 
cifically inhibitable with hapten.  The relationship of this  system with  other 
idiotypic systems and the possible autoimmune implications of autoantiidio- 
typic antibodies are discussed. 
I  gratefully acknowledge the technical assistance of Mrs. Imogene Davis. 
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